Table 1 Clinical characteristics of the study population
From: A LASSO-derived risk model for long-term mortality in Chinese patients with acute coronary syndrome
Characteristics | Total | Patients survived | Patients died | P Value |
|---|---|---|---|---|
No. of patients | N = 2174 | N = 1981 | N = 193 | |
Age | 64.54 ± 10.57 | 63.96 ± 10.54 | 70.54 ± 8.83 | <0.001 |
Gender, man, n (%) | 1713 (78.79%) | 1572 (79.35) | 141 (73.06) | 0.041 |
Medical history | ||||
Pre-hypertension, n (%) | 1183 (54.64) | 1072 (54.31) | 111 (58.12) | 0.313 |
Pre-diabetes mellitus, n (%) | 470 (21.72) | 412 (20.88) | 58 (30.37) | 0.002 |
Pre-heart failure, n (%) | 83 (5.3) | 60 (4.3) | 23 (12.2) | <0.001 |
Pre-myocardial infarction, n (%) | 379 (23.9) | 329 (23.6) | 50 (26.3) | 0.475 |
At admission | ||||
HR, beats/min | 74.99 ± 26.09 | 74.51 ± 26.69 | 79.96 ± 18.05 | <0.001 |
SBP, mm Hg | 130.51 ± 22.1 | 130.68 ± 21.52 | 128.79 ± 27.43 | 0.263 |
DBP, mm Hg | 76.29 ± 12.8 | 76.52 ± 12.64 | 73.88 ± 14.11 | <0.001 |
LVEF, % | 50.52 ± 24.62 | 50.55 ± 24.95 | 50.22 ± 19.41 | 0.896 |
Risk assessment | ||||
GRACE risk score | 92.95 ± 26.1 | 91.35 ± 25.64 | 109.44 ± 25.2 | <0.001 |
TIMI classification | 4.58 ± 2.03 | 4.39 ± 1.94 | 5.94 ± 2.20 | <0.001 |
Laboratory values | ||||
Serum creatinine, μmol/L | 94.44 ± 51.3 | 92.69 ± 47.87 | 112.37 ± 76 | <0.001 |
Blood glucose, mmol/L | 7.17 ± 3.3 | 7.03 ± 3.11 | 8.59 ± 4.6 | <0.001 |
Total cholesterol, mmol/L | 4.13 ± 1.11 | 4.13 ± 1.1 | 4.09 ± 1.2 | 0.602 |
WBC, n × 109/L | 7.92 ± 5.66 | 7.79 ± 5.75 | 9.23 ± 4.43 | <0.001 |
RBC, n × 1012/L | 4.45 ± 1.11 | 4.47 ± 1.15 | 4.16 ± 0.65 | <0.001 |
Hemoglobin, g/L | 134.22 ± 35.39 | 135.17 ± 36.42 | 124.42 ± 19.89 | <0.001 |
Platelets, n × 109/L | 162.28 ± 61.05 | 161.79 ± 60.75 | 167.33 ± 63.95 | 0.229 |
AST, U/L | 56.91 ± 102.95 | 52.55 ± 81.82 | 102.8 ± 222.7 | <0.001 |
Serum K+, mmol/L | 3.96 ± 0.47 | 3.96 ± 0.45 | 4 ± 0.62 | 0.261 |
Serum Ca2+, mmol/L | 2.32 ± 4.4 | 2.34 ± 4.61 | 2.16 ± 0.18 | 0.619 |
Fibrinogen, g/L | 3.83 ± 11.22 | 3.8 ± 11.46 | 4.18 ± 8.23 | 0.679 |
Discharge medications | ||||
Aspirin, n (%) | 2005 (94.18%) | 1865 (96.68%) | 140 (70.0%) | <0.001 |
Clopidogrel, n (%) | 2002 (94.03%) | 1854 (96.11%) | 148 (74.0%) | <0.001 |
ACEI/ARBs, n (%) | 1228 (57.73%) | 1140 (59.16%) | 88 (44.0%) | <0.001 |
Beta-blockers, n (%) | 1434 (67.45%) | 1340 (69.57%) | 94 (47.0%) | <0.001 |
Statins, n (%) | 1949 (91.55%) | 1807 (93.68%) | 142 (71.0%) | <0.001 |